CureMatch Articles & News
A study performed by UCSD oncologist and CureMatch co-founder Dr. Razelle Kurzrock and colleagues looked at 57 breast cancer patients using next-generation sequencing (NGS), and found that no two were the same. A total of 216 somatic
This Discovery is Expected to Pave the Way for Metabolomic Profiling in the Monitoring and Treatment of Cancer SAN DIEGO, CA – February 23, 2017 – CureMatch, the developer of a decision support platform for combination therapy in cancer, revealed in the 2nd Annual Biomarker Conference new discoveries using metabolomics as a tool for clinical […]
Next-generation sequencing study validates a core principle behind the CureMatch technology SAN DIEGO, CA – February 16, 2017 – CureMatch, the developer of a decision support platform for combination therapy in cancer, today announced that research from their co-founder and Chief Medical Advisor, Dr. Razelle Kurzrock, was selected by the American Society of Clinical Oncology […]
OncoImmunology Publication Validates Need to Determine Specific Subset of Mutations that Elicit Cancer Therapy Response SAN DIEGO, CA – February 7, 2017 – CureMatch, the developer of a Decision Support System for combination therapy in cancer, today revealed in the peer-reviewed journal OncoImmunology the description of a specific mechanism that can potentially be used for selecting […]
Clinical Research Currents today featured CureMatch co-founders Igor Tsigelny, Ph.D. and Razelle Kurzrock, M.D., and discussed CureMatch’s new decision support system.
